Literature DB >> 30060835

Host-Intrinsic Interferon Status in Infection and Immunity.

Beiyun C Liu1, Joseph Sarhan2, Alexander Poltorak3.   

Abstract

Most genetic ablations of interferon (IFN) signaling abolish both the experimentally induced IFN response and constitutive IFN, whose effects are well established in autoimmunity but understudied during infection. In host-pathogen interactions, most IFN-mediated responses are attributed to infection-driven IFN. However, IFNs confer their activity by regulating networks of interferon-stimulated genes (ISGs), a process that requires de novo transcription and translation of both IFN and downstream ISGs through feedback of IFN receptor signaling. Due to the temporal requirement for IFN activity, many rapid antimicrobial responses may instead result from pre-established IFN signature stemming from host-intrinsic processes. Addressing the permeating effects of constitutive IFN is therefore needed to accurately describe immunity as host intrinsic or pathogen induced.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30060835      PMCID: PMC6084451          DOI: 10.1016/j.molmed.2018.06.004

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  97 in total

1.  Interferon beta-1b effects on cytokine mRNA in peripheral mononuclear cells in multiple sclerosis.

Authors:  P V Byskosh; A T Reder
Journal:  Mult Scler       Date:  1996-04       Impact factor: 6.312

2.  Interference phenomena between animal viruses; a review.

Authors:  W HENLE
Journal:  J Immunol       Date:  1950-03       Impact factor: 5.422

3.  Dissection of a type I interferon pathway in controlling bacterial intracellular infection in mice.

Authors:  Juliane Lippmann; Holger C Müller; Jan Naujoks; Christoph Tabeling; Sunny Shin; Martin Witzenrath; Katharina Hellwig; Carsten J Kirschning; Gregory A Taylor; Winfried Barchet; Stefan Bauer; Norbert Suttorp; Craig R Roy; Bastian Opitz
Journal:  Cell Microbiol       Date:  2011-08-24       Impact factor: 3.715

4.  Type I interferon pathway mediates renal ischemia/reperfusion injury.

Authors:  Maria Cecilia S Freitas; Yoichiro Uchida; Charles Lassman; Gabriel M Danovitch; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Transplantation       Date:  2011-07-27       Impact factor: 4.939

Review 5.  Beyond the Triplet Code: Context Cues Transform Translation.

Authors:  Gloria A Brar
Journal:  Cell       Date:  2016-12-15       Impact factor: 41.582

6.  Caspase-11 protects against bacteria that escape the vacuole.

Authors:  Youssef Aachoui; Irina A Leaf; Jon A Hagar; Mary F Fontana; Cristine G Campos; Daniel E Zak; Michael H Tan; Peggy A Cotter; Russell E Vance; Alan Aderem; Edward A Miao
Journal:  Science       Date:  2013-01-24       Impact factor: 47.728

7.  Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock.

Authors:  Jon A Hagar; Daniel A Powell; Youssef Aachoui; Robert K Ernst; Edward A Miao
Journal:  Science       Date:  2013-09-13       Impact factor: 47.728

8.  Trex1 prevents cell-intrinsic initiation of autoimmunity.

Authors:  Daniel B Stetson; Joan S Ko; Thierry Heidmann; Ruslan Medzhitov
Journal:  Cell       Date:  2008-08-22       Impact factor: 41.582

9.  Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

Authors:  Young Sik Cho; Sreerupa Challa; David Moquin; Ryan Genga; Tathagat Dutta Ray; Melissa Guildford; Francis Ka-Ming Chan
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

Review 10.  The role of type 1 interferon in systemic sclerosis.

Authors:  Minghua Wu; Shervin Assassi
Journal:  Front Immunol       Date:  2013-09-06       Impact factor: 7.561

View more
  6 in total

1.  Single-cell sequencing of rotavirus-infected intestinal epithelium reveals cell-type specific epithelial repair and tuft cell infection.

Authors:  Carolyn Bomidi; Matthew Robertson; Cristian Coarfa; Mary K Estes; Sarah E Blutt
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-09       Impact factor: 11.205

2.  TLR3 controls constitutive IFN-β antiviral immunity in human fibroblasts and cortical neurons.

Authors:  Daxing Gao; Michael J Ciancanelli; Peng Zhang; Oliver Harschnitz; Vincent Bondet; Mary Hasek; Jie Chen; Xin Mu; Yuval Itan; Aurélie Cobat; Vanessa Sancho-Shimizu; Benedetta Bigio; Lazaro Lorenzo; Gabriele Ciceri; Jessica McAlpine; Esperanza Anguiano; Emmanuelle Jouanguy; Damien Chaussabel; Isabelle Meyts; Michael S Diamond; Laurent Abel; Sun Hur; Gregory A Smith; Luigi Notarangelo; Darragh Duffy; Lorenz Studer; Jean-Laurent Casanova; Shen-Ying Zhang
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 19.456

3.  Intestinal Epithelial Cells Express Immunomodulatory ISG15 During Active Ulcerative Colitis and Crohn's Disease.

Authors:  Ann Elisabet Østvik; Tarjei Dahl Svendsen; Atle van Beelen Granlund; Berit Doseth; Helene Kolstad Skovdahl; Ingunn Bakke; Silje Thorsvik; Wahida Afroz; Gunnar Andreas Walaas; Tom Eirik Mollnes; Björn Inge Gustafsson; Arne Kristian Sandvik; Torunn Bruland
Journal:  J Crohns Colitis       Date:  2020-07-30       Impact factor: 9.071

Review 4.  IRF and STAT Transcription Factors - From Basic Biology to Roles in Infection, Protective Immunity, and Primary Immunodeficiencies.

Authors:  Trine H Mogensen
Journal:  Front Immunol       Date:  2019-01-08       Impact factor: 7.561

Review 5.  Type I interferons and endoplasmic reticulum stress in health and disease.

Authors:  Jenny Sprooten; Abhishek D Garg
Journal:  Int Rev Cell Mol Biol       Date:  2019-11-19       Impact factor: 6.813

6.  Constitutive TRIM22 Expression in the Respiratory Tract Confers a Pre-Existing Defence Against Influenza A Virus Infection.

Authors:  Matthew Charman; Steven McFarlane; Joanna K Wojtus; Elizabeth Sloan; Rebecca Dewar; Gail Leeming; Mohammed Al-Saadi; Laura Hunter; Miles W Carroll; James P Stewart; Paul Digard; Edward Hutchinson; Chris Boutell
Journal:  Front Cell Infect Microbiol       Date:  2021-09-21       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.